2,3,4,6-tetrachlorophenol has been researched along with Abdominal Epilepsy in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 11 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandt, C; Klein, P; Krauss, GL; Rosenfeld, WE; Serratosa, JM; Steinhoff, BJ; Toledo, M | 1 |
| Karkare, S; Kothare, SV; Shah, YD; Varughese, RT | 1 |
| Ben-Menachem, E; Brandt, C; García Morales, I; Rosenfeld, WE; Santamarina, E; Serratosa, JM; Steinhoff, BJ | 1 |
| Keam, SJ | 1 |
| Aschenbrenner, DS | 1 |
| Dhir, A | 1 |
| Buckley, CT; DeMaagd, G; Waters, OR | 1 |
| Bauer, S; Mann, C; Rosenow, F; Strzelczyk, A; Willems, LM | 1 |
| Mula, M | 1 |
| Steinhoff, BJ | 1 |
| De Caro, C; Iannone, LF; Lattanzi, S; Roberti, R; Russo, E; Zaccara, G | 1 |
6 review(s) available for 2,3,4,6-tetrachlorophenol and Abdominal Epilepsy
| Article | Year |
|---|---|
Practical guidance for the management of adults receiving adjunctive cenobamate for the treatment of focal epilepsy-expert opinion.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Drug Therapy, Combination; Epilepsies, Partial; Expert Testimony; Humans; Tetrazoles | 2021 |
Cenobamate: First Approval.
Topics: Administration, Oral; Adult; Anticonvulsants; Carbamates; Chlorophenols; Drug Approval; Epilepsies, Partial; Epilepsy; Humans; Tetrazoles | 2020 |
Cenobamate for the treatment of focal epilepsies.
Topics: Animals; Anticonvulsants; Carbamates; Chlorophenols; Epilepsies, Partial; Headache; Humans; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome | 2020 |
Pharmacological treatment of focal epilepsy in adults: an evidence based approach.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Epilepsies, Partial; Humans; Tetrazoles | 2021 |
Cenobamate tablets as a treatment for focal-onset seizures in adults.
Topics: Adult; Animals; Anticonvulsants; Carbamates; Chlorophenols; Epilepsies, Partial; Humans; Randomized Controlled Trials as Topic; Tablets; Tetrazoles | 2021 |
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug-Drug Interactions and Tolerability.
Topics: Adult; Animals; Anticonvulsants; Biological Availability; Carbamates; Chlorophenols; Dose-Response Relationship, Drug; Drug Interactions; Epilepsies, Partial; Humans; Randomized Controlled Trials as Topic; Tetrazoles | 2021 |
1 trial(s) available for 2,3,4,6-tetrachlorophenol and Abdominal Epilepsy
| Article | Year |
|---|---|
Onset of efficacy and adverse events during Cenobamate titration period.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Drug Therapy, Combination; Epilepsies, Partial; Humans; Quality of Life; Seizures; Tetrazoles; Treatment Outcome | 2022 |
4 other study(ies) available for 2,3,4,6-tetrachlorophenol and Abdominal Epilepsy
| Article | Year |
|---|---|
Adjunctive use of cenobamate for pediatric refractory focal-onset epilepsy: A single-center retrospective study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamates; Child; Chlorophenols; Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Humans; Retrospective Studies; Seizures; Tetrazoles; Treatment Outcome | 2022 |
New Treatment for Partial-Onset Seizures in Adults.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Drug Approval; Epilepsies, Partial; Humans; Tetrazoles; United States; United States Food and Drug Administration | 2020 |
Cenobamate for the treatment of focal epilepsy.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Epilepsies, Partial; Humans; Seizures; Tetrazoles | 2020 |
Cenobamate: A New Adjunctive Agent for Drug-Resistant Focal Onset Epilepsy.
Topics: Adolescent; Adult; Aged; Animals; Anticonvulsants; Carbamates; Chemotherapy, Adjuvant; Chlorophenols; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Quality of Life; Rats; Tetrazoles; Young Adult | 2021 |